Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Although the incidence of cancer increases with age, older patients are under-represented in cancer treatment trials, resulting in limited data availability in this patient population. Here we present results from pre-defined subgroup analyses conducted by age group (<65 vs ≥65 years) from a rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825296/
https://www.ncbi.nlm.nih.gov/pubmed/24129974
http://dx.doi.org/10.1007/s10549-013-2710-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825296/
https://www.ncbi.nlm.nih.gov/pubmed/24129974
http://dx.doi.org/10.1007/s10549-013-2710-z

Ejemplares similares